logo
  • About Initiator Pharma
    • Mission
    • Scientific and Clinical Advisory Board
    • Goals, strategy and business model
    • CEO Letter
    • History
  • Science
    • Pipeline
    • Pudafensine
      • Clinical programs
        • IPED2015 – Organic Erectile dysfunction
        • IPTN2021 – Neuropathic Pain
      • Preclinical program
        • IPFSD2023 – Female Sexual Dysfunction
    • IP2018
      • Clinical programs
        • IP2018 – Psychogenic Erectile dysfunction
      • Preclinical program
        • IPFSD2023 – Female Sexual Dysfunction
    • Therapeutic Areas
      • Erectile Dysfunction
      • Female Sexual Dysfunction
      • Depression
      • Trigeminal Neuralgia
  • Governance
    • General Meetings
    • Management
    • Board of Directors
    • Auditing
    • Articles of Association
    • Remuneration and incentive program
  • Investors
    • Rights Issue 2025
    • Investment case
    • Financial Reports
    • The Share
    • Ownership Structure
    • Analyst and Media Coverage
    • Financial Calendar
    • Prospectuses
    • Press Releases
    • Subscribe
    • Certified Adviser
  • Media
    • Press Releases
    • Event Calendar
    • Subscribe
  • Contact
Loading..

Financial Calendar

2023
  • Upcoming events
  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • All years
Financial calendar
  • Event calendar
February 17, 2023

Year-end report 2022 (Q4)

Add to calendar
May 2, 2023

Annual Report 2022

Add to calendar
May 5, 2023

Interim Q1 2023 report

Add to calendar
May 26, 2023

Annual General Meeting 2023

Add to calendar
August 25, 2023

Interim report 1st half 2023

Add to calendar
November 10, 2023

Interim Q3 2023 report

Add to calendar
  • Investors
    • Rights Issue 2025
    • Investment case
    • Financial Reports
    • The Share
    • Ownership Structure
    • Analyst and Media Coverage
    • Financial Calendar
    • Prospectuses
    • Press Releases
    • Subscribe
    • Certified Adviser

Share

Read more
Initiator Pharma logo
About Initiator Pharma
  • Mission
  • Scientific and Clinical Advisory Board
  • Goals, strategy and business model
  • CEO Letter
  • History
Science
  • Pipeline
  • Pudafensine
    • Clinical programs
    • Preclinical program
  • IP2018
    • Clinical programs
    • Preclinical program
  • Therapeutic Areas
    • Erectile Dysfunction
    • Female Sexual Dysfunction
    • Depression
    • Trigeminal Neuralgia
Governance
  • General Meetings
  • Management
  • Board of Directors
  • Auditing
  • Articles of Association
  • Remuneration and incentive program
Investors
  • Rights Issue 2025
  • Investment case
  • Financial Reports
  • The Share
  • Ownership Structure
  • Analyst and Media Coverage
  • Financial Calendar
  • Prospectuses
  • Press Releases
  • Subscribe
  • Certified Adviser
Media
  • Press Releases
  • Event Calendar
  • Subscribe
Contact
Edit

Share

Read more
  • Cookies
  • Privacy